Cargando…

MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117(+)CD44(+) ovarian cancer stem cells by regulating epithelial-mesenchymal transition

BACKGROUND: Cancer stem cells (CSCs) are believed to be ‘seed cell’ in cancer recurrence and metastasis. MicroRNAs (miRNAs) can play an important role in the progression of primary tumor towards metastasis by regulating the epithelial-mesenchymal transition (EMT). The goal of this study was to inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Dengyu, Zhang, Yunxia, Wang, Jing, Chen, Junsong, Yang, Cuiping, Cai, Kai, Wang, Xiaoying, Shi, Fangfang, Dou, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729499/ https://www.ncbi.nlm.nih.gov/pubmed/23842108 http://dx.doi.org/10.1186/1757-2215-6-50

Ejemplares similares

Evaluation of characteristics of CD44(+)CD117(+) ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures
por: Chen, Junsong, et al.
Publicado: (2013)

Paclitaxel-Fe(3)O(4) nanoparticles inhibit growth of CD138(−) CD34(−) tumor stem-like cells in multiple myeloma-bearing mice
por: Yang, Cuiping, et al.
Publicado: (2013)

Gene therapy of ovarian cancer using IL-21-secreting human umbilical cord mesenchymal stem cells in nude mice
por: Zhang, Yunxia, et al.
Publicado: (2014)

Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells
por: Zhang, Rongrong, et al.
Publicado: (2015)

Chemokine CCL20 promotes the paclitaxel resistance of CD44(+)CD117(+) cells via the Notch1 signaling pathway in ovarian cancer
por: Chen, Min, et al.
Publicado: (2021)

Tumorigenic and Metastatic Role of CD44(−/low)/CD24(−/low) Cells in Luminal Breast Cancer
por: Vikram, Rajeev, et al.
Publicado: (2020)

miR-26b regulates cell proliferation and apoptosis of CD117+CD44+ ovarian cancer stem cells by targeting PTEN
por: Gao, Zubiao, et al.
Publicado: (2021)

Increased invasion and tumorigenicity capacity of CD44(+)/CD24(-) breast cancer MCF7 cells in vitro and in nude mice
por: Yan, Wenxing, et al.
Publicado: (2013)

Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel
por: Khayrani, Apriliana Cahya, et al.
Publicado: (2019)

CD44 is overexpressed and correlated with tumor progression in gallbladder cancer
por: He, Yuting, et al.
Publicado: (2018)

CD117(+)CD44(+) Stem T Cells Develop in the Thymus and Potently Suppress T-cell Proliferation by Modulating the CTLA-4 Pathway
por: Wei, Yang, et al.
Publicado: (2017)

Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer
por: Miwa, Takeshi, et al.
Publicado: (2017)

Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis
por: Chen, Fang, et al.
Publicado: (2018)

Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition
por: Wang, Jing, et al.
Publicado: (2015)

Formation of $^{117}In-H$ pairs after annealing of GaN implanted with $^{117}Cd(^{117}In)$
por: Dietrich, M, et al.
Publicado: (2001)

Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells
por: Fan, Yuanchun, et al.
Publicado: (2022)

Interaction of CD200 Overexpression on Tumor Cells with CD200R1 Overexpression on Stromal Cells: An Escape from the Host Immune Response in Rectal Cancer Patients
por: Bisgin, Atil, et al.
Publicado: (2019)

CD200/CD200 receptor axis in psoriasis vulgaris
por: Ismail, Aisha A., et al.
Publicado: (2020)

CD200:CD200R Interactions and Their Importance in Immunoregulation
por: Kotwica-Mojzych, Katarzyna, et al.
Publicado: (2021)

Juglone and KPT6566 Suppress the Tumorigenic Potential of CD44(+)CD133(+) Tumor-Initiating Caco-2 Cells In Vitro and In Vivo
por: Kim, Junghoon, et al.
Publicado: (2022)

Rabbit CD200R binds host CD200 but not CD200-like proteins from poxviruses
por: Akkaya, Munir, et al.
Publicado: (2016)

Expression and Function of CD44 in Epithelial Ovarian Carcinoma
por: Sacks, Joelle D., et al.
Publicado: (2015)

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
por: Adams, April, et al.
Publicado: (2015)

Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis
por: Yang, Bikang, et al.
Publicado: (2017)

Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2015)

Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells
por: Arpicco, Silvia, et al.
Publicado: (2013)

Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells
por: Liu, Jing, et al.
Publicado: (2013)

Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness
por: Shnaider, Polina V., et al.
Publicado: (2023)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

Understanding the role of CD44V6 in ovarian cancer
por: Zhang, Hui-Feng, et al.
Publicado: (2017)

CD200-CD200R Interaction: An Important Regulator After Stroke
por: Zhao, Xu, et al.
Publicado: (2019)

Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
por: Choe, Deborah, et al.
Publicado: (2023)

CD200 and CD200R Expression on Peripheral Blood Lymphocytes and Serum CD200 Concentration as a New Marker of Endometriosis
por: Abramiuk, Monika, et al.
Publicado: (2020)

sCD44 overexpression increases intraocular pressure and aqueous outflow resistance
por: Giovingo, Michael, et al.
Publicado: (2013)

CD200‐CD200R1 signaling pathway regulates neuroinflammation after stroke
por: Zhao, Shou‐cai, et al.
Publicado: (2020)

CD44(+) fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3‐CD44‐IGF2 signalling
por: Liu, Yonglei, et al.
Publicado: (2017)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

The CD44(high) Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression
por: Basak, Saroj K., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_arj59h5unliu45rbtjlo82pfk9